Is iShares Core MSCI EAFE ETF undervalued?

iShares Core MSCI EAFE ETF Valuation Overview

Last updated: 13 February 2026

iShares Core MSCI EAFE ETF is an exchange-traded fund providing exposure to Financials, Industrials, Technology. Top holdings include ASML, ROG, AZN, HSBA, NOVN.

Current Valuation

iShares Core MSCI EAFE ETF

Ticker: IEFA
Fair Value 0.0% UNDERVALUED
Timing Signal EXTREMELY OVERHEATED
Risk Level LOW
Confidence HIGH

The iShares Core MSCI EAFE ETF (IEFA) is currently assessed as undervalued, meaning its price is lower than what analysts believe it should be. However, the market is considered extremely overheated, suggesting that prices may be rising too quickly. This ETF focuses on companies in Europe, Asia, and the Far East.

Analysis date: 13 February 2026
Indicators only. No investment advice.

Quick overview

The iShares Core MSCI EAFE ETF (IEFA) is currently assessed as undervalued, meaning its price is lower than what analysts believe it should be. However, the market is considered extremely overheated, suggesting that prices may be rising too quickly. This ETF focuses on companies in Europe, Asia, and the Far East.

What moved the ETF last month?

  • Strong performance in the financial sector, which makes up over 11% of the ETF, helped boost its value.
  • Major companies like ASML and AstraZeneca are among the top holdings, and their stock movements significantly influence the ETF.
  • Global market trends, including rising interest rates, have affected investor sentiment and stock prices.
  • Economic recovery in key regions has led to increased investor confidence, pushing prices higher.
  • The ETF's low risk level indicates that it tends to be more stable compared to other investments.

In short: The ETF's value has been driven by strong sector performance and positive market trends, despite being in an overheated state.

Why is the ETF valued this way today?

  • The ETF is currently priced at a trailing price-to-earnings ratio of about 24.5, which means investors are paying around $24.50 for every $1 of earnings. This is relatively high, indicating that investors expect good future growth.
  • The profit margin of 13.2% shows that the companies in this ETF keep a decent portion of their revenue as profit,

Key Metrics

Valuation

Trailing P/E 24.5x
Forward P/E 20.2x
Price/Book 6.8x

Quality

ROE 23.9%
Profit Margin 13.2%

Growth

Revenue Growth 2.8%
Earnings Growth 39.1%

Factor Scores

Value Score -0.03
Quality Score +0.04
Growth Score -0.02

Top Holdings Impact

Ticker Name Weight P/E Score
ASML ASML Holding N.V. - Ne... 2.1% 47.9x -3.0%
ROG Rogers Corporation 1.2% N/A -1.4%
AZN AstraZeneca PLC 1.2% 31.3x -3.1%
HSBA HSBA 1.2% N/A +0.0%
NOVN NOVN 1.2% N/A +0.0%

Valuation History

Coming soon

Line chart: Fair value curve and current valuation curve

Table: Monthly valuation history (fair value %, timing, risk, confidence)